.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Novartis
Deloitte
AstraZeneca
Fuji
Harvard Business School
Dow
Merck
Covington

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075944

« Back to Dashboard
NDA 075944 describes LISINOPRIL, which is a drug marketed by Apotex Inc, Wockhardt, Sandoz, Invagen Pharms, Lupin, Aurobindo, Prinston Inc, Sun Pharm Inds Ltd, Ivax Sub Teva Pharms, Accord Hlthcare, Watson Labs, Hikma Intl Pharms, Mylan, and Teva, and is included in thirty-one NDAs. It is available from seventy-five suppliers. Additional details are available on the LISINOPRIL profile page.

The generic ingredient in LISINOPRIL is hydrochlorothiazide; lisinopril. There are thirty-one drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

Summary for NDA: 075944

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075944

Suppliers and Packaging for NDA: 075944

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LISINOPRIL
lisinopril
TABLET;ORAL 075944 ANDA PD-Rx Pharmaceuticals, Inc. 43063-138 43063-138-90 90 TABLET in 1 BOTTLE, PLASTIC (43063-138-90)
LISINOPRIL
lisinopril
TABLET;ORAL 075944 ANDA State of Florida DOH Central Pharmacy 53808-0701 53808-0701-1 30 TABLET in 1 BLISTER PACK (53808-0701-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Jul 1, 2002TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Jul 1, 2002TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jul 1, 2002TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Dow
Covington
Argus Health
Farmers Insurance
Queensland Health
AstraZeneca
Chubb
Accenture
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot